3 completed, 1 recruiting. 2 Phase 4, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow OraVerse: new trials by email Literature Review of OraVerse trials Research Report on OraVerse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in Children OraVerse - Soft Tissue Injuries | Phase 3 | Recruiting | Cairo University | 100 | 2025-07-05 | 2025-07-10 |
| Reversing the Effects of 0.5% Bupivacaine OraVerse, Saline Water (Control) - Anesthesia, Local | Phase 4 | Completed | Dalhousie University | 44 | 2017-02-10 | 2020-01-29 |
| Reversing the Effects of 2% Lidocaine Phentolamine mesylate, Water - Soft Tissue Anaesthesia | Not applicable | Completed | Dalhousie University | 38 | 2015-10-01 | 2016-10-14 |
| Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients OraVerse, Sham injection - Dental Anesthesia, Anesthesia, Local | Phase 4 | Completed | Novocol Pharmaceutical of Canada, Inc. | 150 | 2012-02-01 | 2014-08-29 |
Dalhousie University (2) · Cairo University (1) · Novocol Pharmaceutical of Canada, Inc. (1)
Canada (2) · Egypt (1) · United States (1)
Adam Marberger, DDS (1) · Brent Lin, DMD (1) · Elliot Hersh, DMD,MS,PhD (1) · Joel Berg, DDS,MS (1) · Judith Chin, DDS,MS (1) · Paul Casamassimo, MS,DDS (1) · Paul Moore, DMD,PhD,MPH (1) · Pierre-Luc Michaud, DMD, MSc, FRCDC (1) · Pierre-Luc Michaud, MSc (1)